Featured Industry Insights
Latest Industry Insights
Industry Insight
Why the Time Is Now for Allogeneic Cell Therapies
Andrew Schulman explores why we need allogeneic therapies, the importance of collaboration to keep the momentum, and challenges and predictions for the future.
Industry Insight
Exploring Key Challenges in Life Science R&D
Technology Networks spoke to Dr. Markus Gershater to learn more about Synthace's Lab automation & experimentation in life science R&D 2023-2024 report, its findings and their significance.
Industry Insight
Accelerating Single-Cell Research with Powerful Dispensing
Join us for an interview with HP's Christie Dudenhoefer, manager of Life Science Solutions, and Dr. Ryan Kelly, professor in the Department of Chemistry at Brigham Young University, to learn how HP's D100 single-cell dispenser is being utilized.
Industry Insight
New Facility Aims To Accelerate Cell Therapy Development
Technology Networks spoke to the CEO of the Novo Nordisk Foundation Cellerator, Dr. Thomas H.R. Carlsen, to find out more about their new world-class facility that will focus on upscaling cell therapy development.
Industry Insight
Human Tissue-Based Materials for 3D Bioprinting
Technology Networks spoke to Dr. Jasper Van Hoorick to learn more about the future of bioprinting, the benefits of animal-free bioinks and the development of human tissue-based bioinks.
Industry Insight
Partnerships Provide Automated Library Preparation Solutions
We spoke to Amit Patel, product marketing director at PacBio, to learn more about PacBio Compatible, the new collaborations and what benefits they will bring to customers.
Industry Insight
How To Build a Data-Centric Future for Biotechnology
In this op-ed, Markus Gershater delves into different aspects of the data we’ll need to generate to help us truly understand the biological systems we deal with.
Industry Insight
Revolutionizing Newborn Screening Through Next-Generation Sequencing
A recent study has shown the clinical value of proactive, sequencing-based screening in apparently healthy newborns for medically actionable conditions. How might these findings impact the current NBS landscape and what does it mean to the healthcare system on the global level?
Industry Insight
What Does Sustainability Accreditation Really Mean for Scientific Companies?
With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.
Industry Insight
Global Sustainability: Lab Goals, Actions and Measuring Success
Scientists around the world are increasingly aware of the environmental footprint of their laboratories, and many are adjusting the way they work day-to-day to offset this impact. In this Industry Insights interview, Agilent's Dr. Michael Frank discusses the safety and efficiency considerations that are fundamentally linked to sustainability and considers why more labs aren’t utilizing consulting services to help them achieve their sustainability goals.
Advertisement
